Lu Q. Le, Ph.D.
Affiliations: | 2002 | University of California, Los Angeles, Los Angeles, CA |
Area:
Immunology, Genetics, Cell BiologyGoogle:
"Lu Le"Parents
Sign in to add mentor| Owen N. Witte | grad student | 2002 | UCLA | |
| (The biological consequences of G2A function in lymphocyte growth control and leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mo J, Anastasaki C, Chen Z, et al. (2020) Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins. The Journal of Clinical Investigation |
| Brosseau JP, Liao CP, Le LQ. (2020) Translating current basic research into future therapies for neurofibromatosis type 1. British Journal of Cancer |
| Chen Z, Mo J, Brosseau J, et al. (2020) Abstract B23: A novel model of neurofibroma that deciphers its developmental origin and susceptibility to modification by the Hippo pathway Molecular Cancer Research. 18 |
| Le LQ, Cooper JM, Patel AJ, et al. (2019) Overcoming BET inhibitor resistance in malignant peripheral nerve sheath tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Brosseau JP, Liao CP, Wang Y, et al. (2018) NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation. Nature Communications. 9: 5014 |
| Chen Z, Mo J, Brosseau JP, et al. (2018) Spatiotemporal loss of NF1 in Schwann cell lineage leads to different types of cutaneous neurofibroma susceptible to modification by the Hippo pathway. Cancer Discovery |
| Blakeley JO, Wolkenstein P, Widemann BC, et al. (2018) Creating a comprehensive research strategy for cutaneous neurofibromas. Neurology. 91: S1-S4 |
| Allaway RJ, Gosline SJC, La Rosa S, et al. (2018) Cutaneous neurofibromas in the genomics era: current understanding and open questions. British Journal of Cancer |
| Fisher MJ, Belzberg AJ, de Blank P, et al. (2018) 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. American Journal of Medical Genetics. Part A. 176: 1258-1269 |
| Cooper JM, Patel AJ, Chen Z, et al. (2018) Abstract 5797: BET inhibitor synthetic lethality in malignant peripheral nerve sheath tumors Cancer Research. 78: 5797-5797 |